Protein Science
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print February 1, 2006, 10.1110/ps.051822606
Protein Science (2006), 15:609-619. Published by Cold Spring Harbor Laboratory Press. Copyright © 2006 The Protein Society
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ps.051822606v1
15/3/609    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, R. A.
Right arrow Articles by Priola, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, R. A.
Right arrow Articles by Priola, S. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation

Roger A. Moore1, Christian Herzog3, John Errett1, David A. Kocisko1, Kevin M. Arnold1, Stanley F. Hayes2 and Suzette A. Priola1

1 The Laboratory of Persistent Viral Diseases and 2 Electron Microscopy Branch, Rocky Mountain Laboratories, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840, USA
3 Commissariat àl’Energie Atomique, Département de Recherche Médicale, BP6 92265 Fontenay-aux-Roses Cedex, France

(RECEIVED August 30, 2005; FINAL REVISION November 14, 2005; ACCEPTED November 28, 2005)

A central feature of transmissible spongiform encephalopathies (TSE or prion diseases) involves the conversion of a normal, protease-sensitive glycoprotein termed prion protein (PrP-sen) into a pro-tease-resistant form, termed PrP-res. The N terminus of PrP-sen has five copies of a repeating eight amino acid sequence (octapeptide repeat). The presence of one to nine extra copies of this motif is associated with a heritable form of Creutzfeld-Jakob disease (CJD) in humans. An increasing number of octapeptide repeats correlates with earlier CJD onset, suggesting that the rate at which PrP-sen misfolds into PrP-res may be influenced by these mutations. In order to determine if octapeptide repeat insertions influence the rate at which PrP-res is formed, we used a hamster PrP amyloid-forming peptide (residues 23–144) into which two to 10 extra octapeptide repeats were inserted. The spontaneous formation of protease-resistant PrP amyloid from these peptides was more rapid in response to an increased number of octapeptide repeats. Furthermore, experiments using full-length glycosylated hamster PrP-sen demonstrated that PrP-res formation also occurred more rapidly from PrP-sen molecules expressing 10 extra copies of the octapeptide repeat. The rate increase for PrP-res formation did not appear to be due to any influence of the octapeptide repeat region on PrP structure, but rather to more rapid binding between PrP molecules. Our data from both models support the hypothesis that extra octapeptide repeats in PrP increase the rate at which protease resistant PrP is formed which in turn may affect the rate of disease onset in familial forms of CJD.

Keywords: prion; fibril; amyloid; kinetics; octapeptide repeat; insertional mutations

Abbreviations: PrP, prion protein • HaPrP, hamster prion protein • TSE, transmissible spongiform encephalopathies

Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.051822606.


Reprint requests to: SuzetteA. Priola, The Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy & Infectious Diseases, National Institutes of Health, 903 S. 4th Street, Hamilton, Montana 59840, USA; e-mail: spriola{at}nih.gov; fax: 406-363-9286.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. J. Helmus, K. Surewicz, P. S. Nadaud, W. K. Surewicz, and C. P. Jaroniec
Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils
PNAS, April 29, 2008; 105(17): 6284 - 6289.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Dong, J. D. Bloom, V. Goncharov, M. Chattopadhyay, G. L. Millhauser, D. G. Lynn, T. Scheibel, and S. Lindquist
Probing the Role of PrP Repeats in Conformational Conversion and Amyloid Assembly of Chimeric Yeast Prions
J. Biol. Chem., November 23, 2007; 282(47): 34204 - 34212.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. M. H. Tank, D. A. Harris, A. A. Desai, and H. L. True
Prion Protein Repeat Expansion Results in Increased Aggregation and Reveals Phenotypic Variability
Mol. Cell. Biol., August 1, 2007; 27(15): 5445 - 5455.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Sun, L. Breydo, N. Makarava, Q. Yang, O. V. Bocharova, and I. V. Baskakov
Site-specific Conformational Studies of Prion Protein (PrP) Amyloid Fibrils Revealed Two Cooperative Folding Domains within Amyloid Structure
J. Biol. Chem., March 23, 2007; 282(12): 9090 - 9097.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Shiraishi, H. Utsunomiya, and M. Nishikimi
Combination of NADPH and Copper Ions Generates Proteinase K-resistant Aggregates from Recombinant Prion Protein
J. Biol. Chem., November 17, 2006; 281(46): 34880 - 34887.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Protein Society.